ICU Intense Light for Critical Illness
This trial will elucidate the influence of intense light therapy pretreatment in patients undergoing cardiac surgery. Hypotheses are that intense light exposure is associated with the peripheral stabilization of Per2 in human buccal swabs and plasma samples before surgery and with a decrease of Troponin I levels after surgery. Additionally, light therapy may lead to Per2 dependent metabolic optimization in the human cardiac tissue.
- Critical Illness
- Myocardial Ischemia
- Endothelial Dysfunction
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Find a site
Who is running the clinical trial?
Frequently Asked Questions
What is the participant capacity of this research endeavor?
"Affirmative. According to information published on clinicaltrials.gov, this investigation is still recruiting patients which began being sought after the 12th of July 2019 and was most recently updated on the 2nd of May 2022. The research team needs approximately 70 participants from one location for the study"
Is enrollment open to participants of any age below seventy-five?
"This experiment permits entry from those aged 18 to 90. 63 clinical trials are available for youth, while 812 are open to the elderly population."
Are any more participants being welcomed into this experiment?
"That is correct. Per the information posted on clinicaltrials.gov, this trial is currently recruiting patients and was first announced on July 12th 2019 before being updated lastly on May 2nd 2022. The study needs 70 participants from a single medical centre in order to proceed."
Could I potentially partake in this clinical experiment?
"This research is recruiting 70 candidiates, aged between 18 and 90, who have a diagnosis of myocardial infarction. Applicants must satisfy the following requirements: undergoing primary sternotomy cardiac surgery; being in sinus rhythm during their procedure; and falling within the specified age bracket."